Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Other Accumulated Expenses (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Other Accumulated Expenses came in at $457.0 million in Q2 2026, down 25.45% year-over-year from $613.0 million in Q2 2025, and up 10.65% quarter-over-quarter from $413.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Other Accumulated Expenses (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Other Accumulated Expenses across 15 years of filings, most recently posting $457.0 million for Q2 2026.

  • In Q2 2026, Other Accumulated Expenses fell 25.45% year-over-year to $457.0 million; the TTM figure through Jun 2026 stood at $457.0 million (down 25.45% YoY), while the FY2025 annual figure was $489.0 million, up 36.21% from the prior year.
  • Other Accumulated Expenses came in at $457.0 million for Q2 2026 at Iqvia Holdings, up from $413.0 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $613.0 million in Q2 2025 to a low of $137.0 million in Q3 2023.
  • Average Other Accumulated Expenses over 5 years is $307.4 million, with a median of $325.0 million recorded in 2023.
  • Year-over-year, Other Accumulated Expenses jumped 325.69% in 2025 and fell 25.45% in 2026.
  • Over 5 years, Other Accumulated Expenses stood at $368.0 million in 2022, then slipped by 10.05% to $331.0 million in 2023, then rose by 8.46% to $359.0 million in 2024, then jumped by 36.21% to $489.0 million in 2025, then declined by 6.54% to $457.0 million in 2026.
  • Per Business Quant data, the three most recent Other Accumulated Expenses figures were $457.0 million in Q2 2026, $413.0 million in Q1 2026, and $489.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 457.00 Mn
Mar 31, 2026 413.00 Mn
Dec 31, 2025 489.00 Mn
Sep 30, 2025 515.00 Mn
Jun 30, 2025 613.00 Mn
Mar 31, 2025 319.00 Mn
Dec 31, 2024 359.00 Mn
Sep 30, 2024 354.00 Mn
Jun 30, 2024 144.00 Mn
Mar 31, 2024 207.00 Mn
Dec 31, 2023 331.00 Mn
Sep 30, 2023 137.00 Mn
Jun 30, 2023 140.00 Mn
Mar 31, 2023 157.00 Mn
Dec 31, 2022 368.00 Mn
Sep 30, 2022 165.00 Mn
Jun 30, 2022 177.00 Mn
Mar 31, 2022 189.00 Mn
Dec 31, 2021 311.00 Mn
Sep 30, 2021 214.00 Mn